Pharmaceutical Raw Materials Industry

An Expert's View about Pharmaceuticals in China

Last updated: 10 Sep 2011

China Pharmaceutical Raw Materials Mfg. Industry Research and Statistics

Shandong province has most leading pharmaceutical raw materials mfg. enterprises, and among all top 100 large pharmaceutical raw materials mfg. enterprises across China, 20 are located in Shandong. According to China Pharmaceutical Raw Materials Mfg. Industry Profile - the industry research report issued by Zeefer Consulting, Jiangsu, Zhejiang and Shandong are the major production bases for pharmaceutical raw materials mfg. industry in China. Hebei, Henan, Shanghai, Guangdong, Sichuan, Tianjin and Liaoning are the secondary distribution areas for this industry.

In terms of market size, in 2009, pharmaceutical raw materials mfg. enterprises above designated size achieved a sales revenue of more than USD 20 billion. The total number of enterprises above designated size in pharmaceutical raw materials mfg. industry was more than 1,000, a rise of more than 9% on a year-on-year basis. On an annual average, total employees in pharmaceutical raw materials mfg. industry exceeded 305,000, an increase of more than 3% on a year-on-year basis. The total export delivery value exceeded USD 5 billion, almost same with last year.

In terms of industry-wide profit, in 2009, profits of enterprises above designated size in pharmaceutical raw materials mfg. industry added up to more than USD 2 billion, a growth of more than 10% on a year-on-year basis. The averaged profit margin of enterprises in pharmaceutical raw materials mfg. industry was higher than 8%. A total of more than 150 enterprises suffered a loss, and the total loss of these enterprises amounted to more than USD 100 million.

In terms of market position of foreign enterprises in China, in 2009, there were more than 200 foreign enterprises above designated size engaged in pharmaceutical raw materials mfg. production in China, accounting for more than 15% of all pharmaceutical raw materials mfg. enterprises across China. Foreign enterprises in China pharmaceutical raw materials mfg. industry achieved a ratio of return on assets of more than 9%, higher than the industry average.

...
Full content of China Pharmaceutical Raw Materials Mfg. Industry Analysis:

http://www.allchinareports.com/china-pharmaceuticals-medical-devices-industry/pharmaceutical-industry-analysis/china-pharmaceutical-raw-materials-mfg.-industry-research-and-statistics.html

***********************************************************************************
The analyses above are extracted from the industry report: China Pharmaceutical Raw Materials Mfg. Industry Profile
 


Posted: 04 September 2011, last updated 10 September 2011

See more from Pharmaceuticals in China

Expert Views    
Bio-Pharma: China 2010 - 2020   By Exolus International Advisory
Biopharmaceutical Opportunities   By UK Trade & Investment
Cosmetics Market in South China   By UK Trade & Investment
Medical Technology Opportunities   By UK Trade & Investment
Latest News    
Pharmaceutical Distribution Programme   By Hong Kong Trade Development Council (HKTDC)